Page last updated: 2024-08-23

enoximone and Shock, Cardiogenic

enoximone has been researched along with Shock, Cardiogenic in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (8.33)	18.7374
1990's	10 (41.67)	18.2507
2000's	7 (29.17)	29.6817
2010's	4 (16.67)	24.3611
2020's	1 (4.17)	2.80

Authors

Authors	Studies
Efremov, L; Frantz, S; Mikolajczyk, R; Schumann, J; Sedding, D; Tongers, J; Uhlig, K	1
Frantz, S; Henrich, EC; Prondzinsky, R; Schumann, J; Strobl, H; Thiele, H; Unverzagt, S; Weiche, S; Werdan, K	1
Caliskan, K; Delnoij, TS; Donker, DW; Maessen, JG; Weerwind, PW; Wetzels, AE	1
Buerke, M; Haerting, J; Hirsch, K; Prondzinsky, R; Thiele, H; Unverzagt, S; Wachsmuth, L; Werdan, K	1
Constantinescu, AA; den Uil, CA; Jewbali, LS; Lagrand, WK; Nieman, K; Simoons, ML; Spronk, PE; Struijs, A; van der Ent, M	1
Fuhrmann, JT; Rauwolf, T; Schmeisser, A; Schoen, SP; Schulze, MR; Strasser, RH; Weinbrenner, C; Wunderlich, C	1
Buerke, M; Prondzinsky, R	1
Rijnders, BJ	1
Berthelsen, PG	1
Beute, J	1
Böhm, M; Hammer, B; Link, A; Weisgerber, K	1
Hausmann, H; Hennig, F; Hetzer, R; Lehmkuhl, HB; Potapov, EV; Sodian, R; Volk, HD; Wagner, FD	1
Goullon, A; Ries, D	1
Loisance, D; Sailly, JC	1
Hake, U; Iversen, S; Jakob, H; Mayer, E; Oelert, H; Schmiedt, W	1
Benvenuti, C; Lebrun, T; Leclerc, A; Loisance, D; Sailly, JC	1
Lehot, JJ	1
Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois-Randé, JL; Hillion, ML; Loisance, D	1
Berré, J; Kahn, RJ; Léon, M; Mélot, C; Vincent, JL	1
Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois-Randé, JL; Duval-Moulin, AM; Lellouche, D; Loisance, D; Merlet, P; Saal, JP	1
Dieterich, HA; Dressler, HT; Fell, JJ; Stegmann, T; Zeplin, HE	1
Berré, J; Léon, M; Vincent, JL	1
Dieterich, HA; Schmid, ER; Turina, M; Zollinger, A	1
Armistead, CW; Berré, J; Cantraine, F; Carlier, E; Coussaert, E; Kahn, RJ; Vincent, JL	1

Reviews

3 review(s) available for enoximone and Shock, Cardiogenic

Article	Year
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. The Cochrane database of systematic reviews, 2020, 11-05, Volume: 11 Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Epinephrine; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Placebos; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents	2020
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. The Cochrane database of systematic reviews, 2018, 01-29, Volume: 1 Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents	2018
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. The Cochrane database of systematic reviews, 2014, Jan-02, Issue:1 Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Enoximone; Humans; Hydrazones; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents	2014

Trials

3 trial(s) available for enoximone and Shock, Cardiogenic

Article	Year
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Critical care medicine, 2008, Volume: 36, Issue:8 Topics: Aged; Cardiotonic Agents; Coronary Care Units; Enoximone; Female; Hemodynamics; Hospital Mortality; Humans; Hydrazones; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Phosphodiesterase Inhibitors; Pyridazines; Shock, Cardiogenic; Simendan	2008
Efficacy of phosphodiesterase inhibitor enoximone in management of postcardiotomy cardiogenic shock. Scandinavian journal of thoracic and cardiovascular surgery, 1992, Volume: 26, Issue:2 Topics: Aged; Cardiac Surgical Procedures; Drug Evaluation; Enoximone; Female; Hemodynamics; Humans; Male; Middle Aged; Postoperative Complications; Shock, Cardiogenic; Treatment Outcome	1992
The role of enoximone in the treatment of cardiogenic shock. Cardiology, 1990, Volume: 77 Suppl 3 Topics: Cardiac Output, Low; Cyclic AMP; Drug Therapy, Combination; Enoximone; Humans; Imidazoles; Myocardium; Phosphodiesterase Inhibitors; Shock, Cardiogenic; Sympathomimetics	1990

Other Studies

18 other study(ies) available for enoximone and Shock, Cardiogenic

Article	Year
Peripheral venoarterial extracorporeal life support despite impending left ventricular thrombosis: a bridge to resolution. Journal of cardiothoracic and vascular anesthesia, 2013, Volume: 27, Issue:4 Topics: Advanced Cardiac Life Support; Anticoagulants; Biopsy; Enoximone; Extracorporeal Circulation; Heparin; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Vasodilator Agents; Venous Thrombosis; Ventricular Dysfunction, Left	2013
Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock. PloS one, 2014, Volume: 9, Issue:8 Topics: Aged; Aged, 80 and over; Capillaries; Dobutamine; Enoximone; Female; Hemodynamics; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Norepinephrine; Perfusion; Pulmonary Circulation; Resuscitation; Shock, Cardiogenic; Treatment Outcome	2014
Levosimendan in cardiogenic shock: better than enoximone! Critical care medicine, 2008, Volume: 36, Issue:8 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan	2008
Evaluation of 30-day mortality of levosimendan versus enoximone. Critical care medicine, 2009, Volume: 37, Issue:3 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Shock, Cardiogenic; Simendan; Time Factors	2009
Levosimendan or enoximone in refractory cardiogenic shock? Critical care medicine, 2009, Volume: 37, Issue:3 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Shock, Cardiogenic; Simendan	2009
Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Critical care medicine, 2009, Volume: 37, Issue:9 Topics: Cardiotonic Agents; Enoximone; Humans; Hydrazones; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan	2009
[Therapy of verapamil poisoning with noradrenaline and the phosphodiesterase inhibitor enoximone]. Deutsche medizinische Wochenschrift (1946), 2002, Sep-27, Volume: 127, Issue:39 Topics: Adult; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Humans; Male; Norepinephrine; Phosphodiesterase Inhibitors; Poisoning; Shock, Cardiogenic; Sympathomimetics; Vasoconstrictor Agents; Vasodilator Agents; Verapamil	2002
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005, Volume: 27, Issue:5 Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Dobutamine; Dopamine; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Enoximone; Epidemiologic Methods; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Nerve Tissue Proteins; Norepinephrine; Peptide Fragments; Prognosis; Shock, Cardiogenic	2005
Experience with the Berlin Heart Assist Device. Artificial organs, 1994, Volume: 18, Issue:7 Topics: Adolescent; Adult; Age Factors; Berlin; Child; Decision Making; Enoximone; Female; Germany; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Risk Factors; Shock, Cardiogenic; Time Factors; Treatment Outcome	1994
Cost-effectiveness in patients awaiting transplantation receiving intravenous inotropic support. European journal of anaesthesiology. Supplement, 1993, Volume: 8 Topics: Cost-Benefit Analysis; Enoximone; Heart Transplantation; Heart-Assist Devices; Humans; Injections, Intravenous; Prospective Studies; Shock, Cardiogenic	1993
[Cost and efficacy of therapeutic strategies in candidates for heart transplantation as salvage therapy]. Archives des maladies du coeur et des vaisseaux, 1992, Volume: 85, Issue:3 Topics: Adult; Cardiotonic Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Enoximone; Female; Heart Transplantation; Heart-Assist Devices; Humans; Imidazoles; Male; Middle Aged; Salvage Therapy; Shock, Cardiogenic	1992
[New positive inotropic drugs]. Annales francaises d'anesthesie et de reanimation, 1991, Volume: 10, Issue:1 Topics: Adrenergic Agonists; Amrinone; Cardiotonic Agents; Dopamine; Enoximone; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Shock, Cardiogenic	1991
[Heart transplantation in acute myocardial infarction]. Archives des maladies du coeur et des vaisseaux, 1991, Volume: 84, Issue:6 Topics: Adult; Cardiotonic Agents; Enoximone; Follow-Up Studies; Heart Transplantation; Heart-Assist Devices; Heart, Artificial; Humans; Imidazoles; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic	1991
Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients. International journal of cardiology, 1990, Volume: 28 Suppl 1 Topics: Adult; Blood Pressure; Cardiac Output; Cardiotonic Agents; Drug Therapy, Combination; Enoximone; Heart Failure; Heart Rate; Humans; Imidazoles; Infusions, Intravenous; Phosphodiesterase Inhibitors; Shock, Cardiogenic; Sympathomimetics	1990
[Medical strategy in patients awaiting emergency heart transplantation]. Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83 Spec No 3 Topics: Adult; Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Contraindications; Critical Care; Diuretics; Dobutamine; Dopamine; Emergencies; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Shock, Cardiogenic	1990
[Oral enoximone therapy as a therapeutic bridging before heart transplantation]. Zeitschrift fur Kardiologie, 1990, Volume: 79, Issue:11 Topics: Administration, Oral; Cardiotonic Agents; Echocardiography; Enoximone; Heart Transplantation; Humans; Imidazoles; Middle Aged; Phosphodiesterase Inhibitors; Preoperative Care; Shock, Cardiogenic	1990
[Enoximone as an alternative to mechanical circulatory support prior to heart transplantation]. Schweizerische medizinische Wochenschrift, 1989, Sep-09, Volume: 119, Issue:36 Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Enoximone; Heart Transplantation; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Shock, Cardiogenic; Stroke Volume	1989
Administration of enoximone in cardiogenic shock. The American journal of cardiology, 1988, Sep-01, Volume: 62, Issue:7 Topics: Blood Gas Analysis; Enoximone; Follow-Up Studies; Hemodynamics; Humans; Imidazoles; Shock, Cardiogenic	1988